Published in Med Clin (Barc) on September 09, 2000
[Recent transmission of tuberculosis in Madrid (Spain): usefulness of molecular techniques]. Med Clin (Barc) (2000) 1.21
[Transmission of tuberculosis in the prisons of Madrid]. Med Clin (Barc) (2000) 1.07
Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest (2001) 3.28
Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 3.19
[Helicobacter pylori: an etiologic factor in chronic gastritis, gastroduodenal ulcer and gastric cancer]. Med Clin (Barc) (1995) 3.09
Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. J Clin Microbiol (1991) 3.00
[Current status of tuberculosis in Spain. A precarious health care perspective with regard to developed countries]. Med Clin (Barc) (1995) 2.58
Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest (1993) 2.56
Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med (1999) 2.40
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08
Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis (1999) 1.88
Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill (2014) 1.66
Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? Int J Tuberc Lung Dis (2005) 1.60
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur Respir J (2010) 1.58
[A contagiousness study in 3071 familial contacts of tuberculosis patients]. Med Clin (Barc) (1997) 1.54
Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis (2001) 1.53
Direct detection of Mycobacterium tuberculosis complex in nonrespiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1997) 1.52
Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine samples. Eur J Clin Microbiol Infect Dis (1999) 1.50
[Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis]. Med Clin (Barc) (2000) 1.48
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis (1995) 1.46
Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J Clin Microbiol (1996) 1.44
[Change in health-related problems of cocaine consumption in Catalonia, Spain]. Med Clin (Barc) (2001) 1.41
[Protected bronchoalveolar lavage: a new endoscopic method in the diagnosis of bacterial pneumonia]. Med Clin (Barc) (1991) 1.40
Diagnostic efficacy of the study of contacts of tuberculosis patients in a high prevalence urban area. Rev Clin Esp (2000) 1.39
Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis (1998) 1.39
[The evolution of AIDS mortality and survival in Barcelona (1981-1997)]. Med Clin (Barc) (1999) 1.38
Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH. Eur J Clin Microbiol Infect Dis (2004) 1.33
The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol (1999) 1.30
Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis (2002) 1.29
Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol (2003) 1.26
Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health (2009) 1.23
Rapid diagnosis of extrapulmonary tuberculosis by ligase chain reaction amplification. J Clin Microbiol (1998) 1.22
Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest (1991) 1.21
Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand J Immunol (2000) 1.20
Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol (1998) 1.19
Characteristics of tuberculosis patients who generate secondary cases. Int J Tuberc Lung Dis (1997) 1.19
Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain. Am J Epidemiol (1998) 1.17
Evaluation of a fluorescence hybridisation assay using peptide nucleic acid probes for identification and differentiation of tuberculous and non-tuberculous mycobacteria in liquid cultures. Eur J Clin Microbiol Infect Dis (2000) 1.17
Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol (2003) 1.16
Inhibitory effect of sodium dodecyl sulfate in detection of Mycobacterium tuberculosis by amplification of rRNA. J Clin Microbiol (1995) 1.14
GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol (2011) 1.13
Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol (2001) 1.12
Assessment of in-vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines. J Hosp Infect (2000) 1.10
Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J (1998) 1.09
Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology (2000) 1.04
Comparison of a nonradiometric system with Bactec 12B and culture on egg-based media for recovery of mycobacteria from clinical specimens. Eur J Clin Microbiol Infect Dis (1998) 1.03
Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol (2011) 1.01
Comparison of radioimmunoassay and enzyme immunoassay kits for detection of Legionella pneumophila serogroup 1 antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol (1997) 1.01
A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest (1993) 1.00
Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Clin Microbiol Infect (2009) 1.00
Multicenter clinical comparison of resin-containing bottles with standard aerobic and anaerobic bottles for culture of microorganisms from blood. Eur J Clin Microbiol Infect Dis (1997) 1.00
Diagnosing TB infection in children: analysis of discordances using in vitro tests and the tuberculin skin test. Eur Respir J (2010) 0.99
Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance. J Clin Microbiol (2006) 0.99
Human tuberculosis due to Mycobacterium bovis: report of 10 cases. Tuber Lung Dis (1992) 0.98
Assessment of a new test to detect Legionella urinary antigen for the diagnosis of Legionnaires' Disease. Diagn Microbiol Infect Dis (2001) 0.97
Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med (1994) 0.96
The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays. Scand J Immunol (2008) 0.96
Towards a 'human-like' model of tuberculosis: intranasal inoculation of LPS induces intragranulomatous lung necrosis in mice infected aerogenically with Mycobacterium tuberculosis. Scand J Immunol (2001) 0.96
Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment. Int J Tuberc Lung Dis (2011) 0.96
Evaluation of Meridian ImmunoCard Mycoplasma test for the detection of Mycoplasma pneumoniae-specific IgM in paediatric patients. Scand J Infect Dis (1998) 0.95
Pneumonia due to Listeria monocytogenes. Clin Infect Dis (1992) 0.95
Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS (2000) 0.95
Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C. J Hepatol (2013) 0.95
Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest (1992) 0.94
Comparative evaluation of two commercial assays for direct detection of Mycobacterium tuberculosis in respiratory specimens. Eur J Clin Microbiol Infect Dis (1998) 0.94
B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis (2004) 0.94
Distribution of surface-exposed antigenic glycolipids in recent clinical isolates of Mycobacterium tuberculosis. Res Microbiol (1997) 0.94
Occurrence of an antigenic triacyl trehalose in clinical isolates and reference strains of Mycobacterium tuberculosis. FEMS Microbiol Lett (1997) 0.93
A small area analysis estimating the prevalence of addiction to opioids in Barcelona, 1993. J Epidemiol Community Health (1999) 0.93
Noninvasive method for diagnosis of visceral leishmaniasis by a latex agglutination test for detection of antigens in urine samples. J Clin Microbiol (2004) 0.93
Use of quantitative and semiquantitative procalcitonin measurements to identify children with sepsis and meningitis. Eur J Clin Microbiol Infect Dis (2003) 0.93
[Discrepancies in the number of deaths from an acute reaction to psychoactive substances recorded in Spain]. Gac Sanit (1999) 0.93
Detection and identification of mycobacteria by amplification of RNA and DNA in pretreated blood and bone marrow aspirates by a simple lysis method. J Clin Microbiol (1997) 0.92
Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis (2000) 0.92
Utility of the rapid antigen detection BinaxNOW Influenza A&B test for detection of novel influenza A (H1N1) virus. Clin Microbiol Infect (2010) 0.92
Rapid detection of Mycobacterium tuberculosis in respiratory specimens, blood and other non-respiratory specimens by amplification of rRNA. Int J Tuberc Lung Dis (1997) 0.91
Molecular and conventional epidemiology of tuberculosis in an inner city district. Int J Tuberc Lung Dis (2001) 0.91
Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona. Clin Microbiol Infect (2009) 0.91
[An evaluation of the epidemiological surveillance system for infectious diseases in the Barcelona Olympic Games of 1992]. Gac Sanit (1995) 0.91
PCR detection of Streptococcus pneumoniae DNA in serum samples for pneumococcal pneumonia diagnosis. Clin Microbiol Infect (2001) 0.91
Letter: Hereditary angioneurotic oedema. Lancet (1974) 0.91
Comparison of the sodium dodecyl sulfate-sodium hydroxide specimen processing method with the C18-carboxypropylbetaine specimen processing method using the MB/BacT liquid culture system. Eur J Clin Microbiol Infect Dis (2003) 0.90
Capillary gas chromatographic analysis of mycolic acid cleavage products, cellular fatty acids, and alcohols of Mycobacterium xenopi. J Clin Microbiol (1989) 0.90
Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report. Clin Infect Dis (1993) 0.89
Evaluation of a Legionella urinary antigen enzyme immunoassay for rapid detection of Legionella pneumophila in water samples. Int J Hyg Environ Health (2007) 0.89
Mycobactericidal activity of chlorine dioxide wipes in a modified prEN 14563 test. J Hosp Infect (2008) 0.88
Usefulness of acr expression for monitoring latent Mycobacterium tuberculosis bacilli in 'in vitro' and 'in vivo' experimental models. Scand J Immunol (2006) 0.88
Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987-2000. Int J Tuberc Lung Dis (2002) 0.88
Seroreactive species-specific lipooligosaccharides of Mycobacterium mucogenicum sp. nov. (formerly Mycobacterium chelonae-like organisms): identification and chemical characterization. Microbiology (1998) 0.87
Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996). Int J Tuberc Lung Dis (2000) 0.87
Predictive factors of HIV-infection in injecting drug users upon incarceration. Eur J Epidemiol (1998) 0.87
Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis (2011) 0.86
Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis (1990) 0.85
Pancoast's syndrome due to chronic pneumonia by Pasteurella multocida. Eur Respir J (1997) 0.85
Mycobacterium xenopi infections in the acquired immunodeficiency syndrome. Ann Intern Med (1988) 0.85
Rapid detection of several mycobacterial species using a polymerase chain reaction reverse hybridisation assay. Eur J Clin Microbiol Infect Dis (2001) 0.85
Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology (1996) 0.85
Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant. Vaccine (2009) 0.84
Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy. Aliment Pharmacol Ther (2006) 0.84
Prevalence of latent tuberculosis infection in inmates recently incarcerated in a men's prison in Barcelona. Int J Tuberc Lung Dis (2012) 0.84
Production of antibodies against glycolipids from the Mycobacterium tuberculosis cell wall in aerosol murine models of tuberculosis. Scand J Immunol (2002) 0.84